Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-78c5997874-xbtfd Total loading time: 0 Render date: 2024-11-09T09:05:07.616Z Has data issue: false hasContentIssue false

Chap 28 - MALIGNANT MESOTHELIOMA AND OTHER MESOTHELIAL PROLIFERATIONS

Published online by Cambridge University Press:  01 March 2011

By
Markku Miettinen
Edited by
Markku Miettinen
Markku Miettinen
Affiliation:
Armed Forces Institute of Pathology, Washington DC
Get access

Summary

Benign mesothelial tumors and malignant mesothelioma are important soft tissue tumors that can present at various sites in the body cavities, and the latter also presents as metastatic tumors in the peripheral soft tissues.

The tumor formerly called a fibrous mesothelioma or localized fibrous tumor is a mesenchymal, fibroblastic, nonmesothelial tumor and is now known as a solitary fibrous tumor. This tumor is unrelated to mesothelioma and is included in Chapter 12.

ADENOMATOID TUMOR

An adenomatoid tumor is a benign mesothelial proliferation that is best known for its occurrence in the internal female and male genitalia: the uterus, fallopian tubes, and epididymis, but it can occur almost anywhere around the serosal surfaces, both in the abdominal and thoracic cavities. It is not uniformly agreed whether an adenomatoid tumor is a benign neoplasm or a form of localized mesothelial hyperplasia.

Clinical Features

Adenomatoid tumors are usually detected in young to middle-aged adults, often incidentally during surgery or imaging studies for unrelated conditions. The most common sites in women are the fallopian tube and uterus, where a small 1-cm to 2-cm adenomatoid tumor is not an uncommon finding in a hysterectomy specimen. In a unique case, an adenomatoid tumor involved the uterus diffusely in a renal transplant patient. Involvement of the ovary has been rarely reported.

In men, the epididymis is the most common site, but the spermatic cord or tunica albuginea can also be involved.

Type
Chapter
Information
Modern Soft Tissue Pathology
Tumors and Non-Neoplastic Conditions
 , pp. 811 - 833
Publisher: Cambridge University Press
Print publication year: 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Huang, CC, Chang, DY, Chen, CK, Chou, YY, Huang, SC. Adenomatoid tumor of the female genital tract. Int J Gynecol Pathol 1995;50:275–280.CrossRefGoogle ScholarPubMed
Nogales, FF, Isaac, MA, Hardisson, D, Bosincu, L, Palacios, J, Ordi, J. Adenomatoid tumor of the uterus: An analysis of 60 cases. Int J Gynecol Pathol 2001;21:31–40.Google Scholar
Cheng, CL, Wee, A. Diffuse uterine adenomatoid tumor in an immunosuppressed renal transplant recipient. Int J Gynecol Pathol 2003;22:198–201.CrossRefGoogle Scholar
Zamecnik, M, Gomolcak, P. Composite multicystic mesothelioma and adenomatoid tumor of the ovary: additional observation suggesting common histogenesis of both lesions. Cesk Patol 2000;38:160–162.Google Scholar
Broth, G, Bullock, WK, Morrow, J. Epididymal tumors: 1. Report of 15 new cases including review of literature. 2: Histochemical study of the so-called adenomatoid tumor. J Urol 1968;100:530–536.CrossRefGoogle ScholarPubMed
Yasuma, T, Saito, S. Adenomatoid tumor of the male genital tract and a pathological study of eight cases and review of the literature. Acta Pathol Jpn 1980;30:883–906.Google Scholar
Barry, P, Chan, KG, Hsu, J, Quek, ML. Adenomatoid tumor of the tunica albuginea. Int J Urol 2005;12:516–518.CrossRefGoogle ScholarPubMed
Raaf, HN, Grant, LD, Santoscoy, C, Levin, HS, Abdul-Karin, FW. Adenomatoid tumor of the adrenal gland: a report of four new cases and a review of the literature. Mod Pathol 1996;9:1046–1051.Google Scholar
Isotalo, PA, Keeney, GL, Sebo, TJ, Riehle, DL, Cheville, JC. Adenomatoid tumor of the adrenal gland: a clinicopathologic study of five cases and review of the literature. Am J Surg Pathol 2003;27:969–977.CrossRefGoogle ScholarPubMed
Craig, JR, Hart, WR. Extragenital adenomatoid tumor: Evidence for the mesothelial theory of origin. Cancer 1979;43:1678–1681.3.0.CO;2-N>CrossRefGoogle Scholar
Overstreet, K, Wixom, C, Shabaik, A, Bouvet, M, Herndier, B. Adenomatoid tumor of the pancreas: a case report with comparison of histology and aspiration cytology. Mod Pathol 2003;16:613–617.CrossRefGoogle ScholarPubMed
Plaza, J, Dominguez, F, Suster, S. Cystic adenomatoid tumor of the mediastinum. Am J Surg Pathol 2004;28:132–138.CrossRefGoogle ScholarPubMed
Natarajan, S, Luhtringer, DJ, Fishbein, MC. Adenomatoid tumor of the heart: report of a case. Am J Surg Pathol 1997;21:1378–1380.CrossRefGoogle ScholarPubMed
Isotalo, PA, Nascimento, AG, Trastek, VF, Wold, , Cheville, JC. Extragenital adenomatoid tumor of a mediastinal lymph node. Mayo Clin Proc 2003;78:350–354.CrossRefGoogle ScholarPubMed
Skinnider, BF, Young, RH. Infarcted adenomatoid tumor: a report of five cases of a facet of a benign neoplasm that may cause diagnostic difficulty. Am J Surg Pathol 2004;28:77–83.CrossRefGoogle ScholarPubMed
Lehto, VP, Miettinen, M, Virtanen, I. Adenomatoid tumor: Immunohistochemical features suggesting a mesothelial origin. Virchows Arch B Cell Pathol 1983;42:153–159.CrossRefGoogle Scholar
Katsube, Y, Mukai, K, Silverberg, SG. Cystic mesothelioma of the peritoneum: a report of five cases and review of literature. Cancer 1982;50:1615–1622.3.0.CO;2-K>CrossRefGoogle Scholar
Carpenter, HA, Laskaster, JR, Lee, RA. Multilocular cysts of the peritoneum. Mayo Clin Proc 1982;57:634–638.Google ScholarPubMed
Schneider, V, Partridge, JR, Gutierrez, F, Hurt, WG, Maizels, MS, Demay, RM. Benign cystic mesothelioma involving the female genital tract: report of four cases. Am J Obstet Gynecol 1983;145:355–359.CrossRefGoogle ScholarPubMed
Weiss, SW, Tavassoli, FA: Multicystic mesothelioma: An analysis of pathological findings and biologic behavior in 37 cases. Am J Surg Pathol 1988;12:737–746.CrossRefGoogle ScholarPubMed
Villaschi, S, Autelitano, F, Santeusanio, G, Balistreri, P. Cystic mesothelioma of the peritoneum: A report of three cases. Am J Clin Pathol 1990;94:758–761.CrossRefGoogle ScholarPubMed
Cuartas, JE, Maheshwari, AV, Qadir, R, Cooper, AJ, Robinson, PG, Pitcher, JD. Benign multicystic peritoneal mesothelioma in a cesarean-section scar presenting as a fungating mass. Int J Clin Oncol 2008;13:275–278.CrossRefGoogle Scholar
Groisman, GM, Kerner, H. Multicystic mesothelioma with endometriosis. Acta Obstet Gynecol Scand 1992;71:642–644.CrossRefGoogle ScholarPubMed
Zotalis, G, Nayar, R, Hicks, DG. Leiomyomatosis peritonealis disseminata, endometriosis, and multicystic peritoneal mesothelioma: an unusual association. Int J Gynecol Pathol 1998;17:178–182.CrossRefGoogle Scholar
Kusuyama, T, Fujita, M. Appendiceal mucinous cystadenoma associated with pseudomyxoma peritonei and multicystic peritoneal mesothelioma: report of a case. Surg Today 1995;25:745–749.CrossRefGoogle ScholarPubMed
Klooster, JM, Lambers, MD, Bommel, EF, Scholten, PC. Successful catheter drainage of recurrent benign multicystic mesothelioma of the peritoneum. Neth J Med 1997;50:246–249.Google ScholarPubMed
Inman, DS, Lambert, AW, Wilkins, DC. Multicystic peritoneal inclusion cysts: the use of CT-guided drainage for symptom control. Ann R Coll Surg Engl 2000;82:196–197.Google ScholarPubMed
Ball, NJ, Urbanski, SJ, Green, FH, Kieser, T. Pleural multicystic mesothelial proliferation: The so-called multicystic mesothelioma. Am J Surg Pathol 1990;14:375–378.CrossRefGoogle ScholarPubMed
Daya, D, McCaughey, WTE. Well-differentiated papillary mesothelioma of the peritoneum: A clinicopathologic study of 22 cases. Cancer 1990;65:292–296.3.0.CO;2-W>CrossRefGoogle ScholarPubMed
Goepel, JR. Benign papillary mesothelioma of the peritoneum: a histological, histochemical and ultrastructural study of six cases. Histopathology 1981;5:21–30.CrossRefGoogle ScholarPubMed
Goldblum, J, Hart, WR. Localized and diffuse mesotheliomas of the genital tract and peritoneum in women: A clinicopathologic study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multicystic mesotheliomas, and localized fibrous tumors. Am J Surg Pathol 1995;19:1124–1137.CrossRefGoogle ScholarPubMed
Hoekstra, AV, Riben, MW, Frumovitz, M, Liu, J, Ramirez, PT. Well-differentiated papillary mesothelioma of the peritoneum: A pathological analysis and review of the literature. Gynecol Oncol 2005;98:161–167.CrossRefGoogle ScholarPubMed
Butnor, KJ, Sporn, TA, Hammar, SP, Roggli, VL. Well-differentiated papillary mesothelioma. Am J Surg Pathol 2001;25:1304–1309.CrossRefGoogle ScholarPubMed
Galateau-Salle, F, Vignaud, JM, Burke, L, Gibbs, A, Brambilla, E, Attanoos, R. Well-differentiated papillary mesothelioma of the pleura: A series of 24 cases. Am J Surg Pathol 2004;28:534–540.CrossRefGoogle ScholarPubMed
Bianchi, C, Bianchi, T. Malignant mesothelioma: Global incidence and relationship with asbestos. Industrial Health 2007;45:379–387.CrossRefGoogle ScholarPubMed
Weill, H, Hughes, JM, Churg, AM. Changing trends in US mesothelioma incidence. Occup Environ Med 2004;61:438–441.CrossRefGoogle ScholarPubMed
Becklake, MR, Bagatin, E, Neder, JA. Asbestos-related diseases of the lungs and pleura: uses, trends and management over the last century. Int J Tuberc Lung Dis 2007;11:356–369.Google ScholarPubMed
Roggli, VA, Sharma, A, Butnor, KJ, Sporn, T, Vollmer, RT. Malignant mesothelioma and occupational exposure to asbestos: a clinicopathologic correlation of 1445 cases. Ultrastruct Pathol 2002;26:55–65.CrossRefGoogle Scholar
McDonald, JC, McDonald, A. Mesothelioma and asbestos exposure. In: Pass, HI, Vogelzang, NJ, Carbone, M (eds). Malignant Mesothelioma. Berlin-Heidelberg-New York, Springer, 2005.Google Scholar
Wagner, JC, Sleggs, CA, Marchand, P. Diffuse pleural mesothelioma and asbestos exposure in the northwestern Cape province. Br J Industr Med 1980;17:260–271.Google Scholar
Carbone, M, Pass, HI, Rizzo, P, Marinetti, M, DiMuzio, M, Mew, DJ. Simian virus 40-like DNA sequences human pleural mesothelioma. Oncogene 1994;9:1781–1790.Google ScholarPubMed
Strickler, HD, Goedert, JJ, Fleming, M, Travis, WD, Williams, AE, Rabkin, CS. Simian virus 40 and pleural mesothelioma in humans. Cancer Epidemiol Biomarkers Prev 1996:5:473–475.Google ScholarPubMed
Cavazza, A, Travis, LB, Travis, WD, Wolfe, JT, Foo, ML, Gillespie, DJ. Post-irradiation malignant mesothelioma. Cancer 1996;77:1379–1385.3.0.CO;2-Y>CrossRefGoogle ScholarPubMed
Brenner, J, Sordillo, PP, Magill, GB, Golbey, RB. Malignant mesothelioma of the pleura: Review of 123 patients. Cancer 1982;49:2431–2435.3.0.CO;2-W>CrossRefGoogle ScholarPubMed
Adams, VI, Unni, KK, Muhn, JR, Jett, JR, Isltrup, DM, Bernatz, PE. Diffuse malignant mesothelioma of pleura: Diagnosis and survival in 92 cases. Cancer 1986;58:1540–1551.3.0.CO;2-5>CrossRefGoogle ScholarPubMed
Antman, K, Shemin, R, Ryan, L, Klegar, K, Osteen, R, Herman, T. Malignant mesothelioma: Prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965–1985. J Clin Oncol 1988;6:147–153.CrossRefGoogle Scholar
Ruffie, P, Feld, R, Minkin, S, Cormier, Y, Boutan-Laroze, A, Ginsberg, R. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: A retrospective study of 332 patients. J Clin Oncol 1989;7:1157–1168.CrossRefGoogle ScholarPubMed
Antman, KH. Natural history and epidemiology of malignant mesothelioma. Chest 1993;103:373S–376S.CrossRefGoogle ScholarPubMed
Chahinian, AP. Clinical presentation and natural history of mesothelioma: pleural and pericardial. In: Pass, In: HI, Vogelzang, NJ, Carbone, M (eds). Malignant Mesothelioma. Berlin-Heidelberg-New York, Springer, 2005.Google Scholar
Kannerstein, M, Churg, A. Peritoneal mesothelioma. Hum Pathol 1977;8:83–94.CrossRefGoogle ScholarPubMed
Kerrigan, SAJ, Turnnir, RT, Clement, PB, Young, RH, Churg, A. Diffuse malignant epithelial mesotheliomas of the peritoneum in women: A clinicopathologic study of 25 cases. Cancer 2002;94:378–385.CrossRefGoogle Scholar
Baker, PM, Clement, PB, Young, RH. Malignant peritoneal mesothelioma in women: A study of 75 cases with emphasis on their morphologic spectrum and differential diagnosis. Am J Clin Pathol 2005;123:724–737.CrossRefGoogle ScholarPubMed
Hassan, R, Alexander, R, Antman, K, Boffetta, P, Churg, A, Coit, D. Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference. Ann Oncol 2006;17:1615–1619.CrossRefGoogle ScholarPubMed
Jones, MA, Young, RH, Scully, RA. Malignant mesothelioma of the tunica vaginalis: A clinicopathologic analysis of 11 cases with review of the literature. Am J Surg Pathol 1995;19:815–825.CrossRefGoogle ScholarPubMed
Churg, A. Paratesticular mesothelial proliferations. Semin Diagn Pathol 2003;20:272–278.CrossRefGoogle ScholarPubMed
Crotty, TB, Myers, JL, Katzenstein, AL, Tazelaar, HD, Swensen, SJ, Churg, A. Localized malignant mesothelioma: A clinicopathologic and flow cytometric study. Am J Surg Pathol 1994;18:357–363.CrossRefGoogle ScholarPubMed
Allen, TG, Cagle, PT, Churg, AM, Colby, TV, Gibbs, AR, Hammar, SP. Localized malignant mesothelioma. Am J Surg Pathol 2005;29:866–873.CrossRefGoogle ScholarPubMed
Battifora, H, McCaughey, WTE. Tumors of the Serous Membranes. Washington, DC, Armed Forces Institute of Pathology, 1995.
Talerman, A, Chilcote, RR, Montero, JR, Okagaki, T. Diffuse malignant peritoneal mesothelioma in a 13-year-old girl. Am J Surg Pathol 1985;9:73–80.CrossRefGoogle Scholar
Nascimento, AG, Keeney, GL, Fletcher, CDM. Deciduoid peritoneal mesothelioma: an unusual phenotype affecting young females. Am J Surg Pathol 1994;18:439–445.CrossRefGoogle ScholarPubMed
Shanks, JH, Harris, M, Banerjee, SS, Eyden, BP, Joglekar, VM, Nicol, A. Mesotheliomas with deciduoid morphology: A morphologic spectrum and a variant not confined to young females. Am J Surg Pathol 2000;24:285–294.CrossRefGoogle Scholar
Ordonez, NG. Epithelial mesothelioma with deciduoid features: A report of four cases. Am J Surg Pathol 2000;24:816–823.CrossRefGoogle ScholarPubMed
Klebe, S, Mahar, A, Henderson, DW, Roggli, VL. Malignant mesothelioma with heterologous elements: clinicopathologic correlation of 27 cases and literature review. Mod Pathol 2008;21:1084–1094.CrossRefGoogle Scholar
Cantin, R, Al-Jabi, M, McCaughey, WTE. Desmoplastic diffuse mesothelioma. Am J Surg Pathol 1982;6:215–222.CrossRefGoogle ScholarPubMed
Mangano, WE, Cagle, PT, Churg, A, Vollmer, RT, Roggli, VL. The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining. Am J Clin Pathol 1998;110:191–199.CrossRefGoogle Scholar
Carella, R, Deleonardi, G, DíErrico, A, Salerno, A, Egarter-Vigl, A, Seebacher, C. Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: A study with logistic regression analysis. Am J Surg Pathol 2001;25:43–50.CrossRefGoogle ScholarPubMed
Wick, MR, Loy, T, Mills, SE, Legier, JF, Manivel, JC. Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: A histochemical, ultrastructural, and immunohistologic study of 103 cases. Hum Pathol 1990;21:759–766.CrossRefGoogle ScholarPubMed
Sheibani, K, Shin, SS, Kezirian, J, Weiss, LM. Ber-Ep4 antibody as a discriminant in the differential diagnosis of malignant mesothelioma versus adenocarcinoma. Am J Surg Pathol 1991;15:779–784.CrossRefGoogle ScholarPubMed
Amin, KM, Litzky, , Smythe, WR. Wilms tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma. Am J Pathol 1995;146:344–356.Google ScholarPubMed
Attanoos, RL, Goddard, H, Gibbs, AR. Mesothelioma-binding antibodies: thrombomodulin, OV 632 and HBME-1 and their use in the diagnosis of malignant mesothelioma. Histopathology 1996;29:209–215.CrossRefGoogle Scholar
Gotzos, V, Vogt, P, Celio, MR. The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type. Pathol Res Pract 1996;192:137–147.CrossRefGoogle ScholarPubMed
Dei Tos, AP, Doglioni, C. Calretinin: a novel tool for diagnostic immunohistochemistry. Adv Anat Pathol 1998;5:61–66.CrossRefGoogle ScholarPubMed
Riera, JR, Astengo-Osuna, C, Longmate, JA, Battifora, H. The immunohistochemical diagnostic panel for epithelial mesothelioma: A reevaluation after heat-induced epitope retrieval. Am J Surg Pathol 1997;21:1409–1417.CrossRefGoogle ScholarPubMed
Cury, PM, Butcher, DN, Fisher, C, Corrin, B, Nicholson, AG. Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to pleura. Mod Pathol 2000;13:107–112.CrossRefGoogle ScholarPubMed
Blobel, GA, Moll, R, Franke, WW, Kayser, KW, Gould, VE. The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance. Am J Pathol 1985;121:235–247.Google ScholarPubMed
Moll, R, Dhouailly, D, Sun, TT. Expression of keratin 5 as a distinctive feature of epithelial and biphasic mesotheliomas: An immunohistochemical study using monoclonal antibody AE14. Virchows Arch B Cell Pathol 1989;58:129–145.CrossRefGoogle ScholarPubMed
Miettinen, M, Sarlomo-Rikala, M. Expression of calretinin, thrombomodulin, keratin 5, and mesothelin in lung carcinomas of different types: an immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleura. Am J Surg Pathol 2003;27:150–158.CrossRefGoogle ScholarPubMed
Ordonez, NG. What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma. Hum Pathol 2007;38:1–16.CrossRefGoogle Scholar
Suster, S, Moran, CA. Applications and limitations of immunohistochemistry in the diagnosis of malignant mesothelioma. Adv Anat Pathol 2006;13:316–329.CrossRefGoogle Scholar
Lucas, DR, Pass, HI, Madan, SK, Adsay, NV, Wali, A, Tabaczka, P. Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study. Histopathology 2003;42:270–279.CrossRefGoogle ScholarPubMed
Hinterberger, M, Reineke, T, Storz, M, Weder, W, Vogt, P, Moch, H. D2–40 and calretinin – a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation. Mod Pathol 2007;20:248–255.CrossRefGoogle ScholarPubMed
Padgett, DM, Cathro, HP, Wick, MR, Mills, SE. Podoplanin is a better immunohistochemical marker for sarcomatoid mesothelioma than calretinin. Am J Surg Pathol 2008;32:123–127.CrossRefGoogle ScholarPubMed
Bolen, JW, Hammar, SP, McNutt, MA. Reactive and neoplastic serosal tissue: A light-microscopic, ultrastructural, and immunocytochemical study. Am J Surg Pathol 1986;10:34–47.CrossRefGoogle ScholarPubMed
Epstein, JI, Budin, RE. Keratin and epithelial membrane antigen immunoreactivity in nonneoplastic fibrous pleural lesions: implications for the diagnosis of desmoplastic mesothelioma. Hum Pathol 1986;17:514–519.CrossRefGoogle Scholar
Oury, TD, Hammar, SP, Roggli, VL. Ultrastructural features of diffuse malignant mesotheliomas. Hum Pathol 1998;29:1382–1392.CrossRefGoogle ScholarPubMed
Rosai, J, Dehner, LP. Nodular mesothelial hyperplasia in hernia sacs: A benign reactive condition simulating a neoplastic process. Cancer 1975;35:165–175.3.0.CO;2-U>CrossRefGoogle ScholarPubMed
Ordonez, NG, Ro, JY, Ayasla, AG. Lesions described as nodular mesothelial hyperplasia are primarily composed of histiocytes. Am J Surg Pathol 1998;22:285–292.CrossRefGoogle ScholarPubMed
Clement, PB, Young, RH. Florid mesothelial hyperplasia associated with ovarian tumors: A potential source of error in tumor diagnosis and staging. Int J Gynecol Pathol 1993;12:51–58.CrossRefGoogle ScholarPubMed
Churg, A, Colby, TV, Cagle, P, Corson, J, Gibbs, AR, Gilks, B. The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol 2000;24:1183–1200.Google ScholarPubMed
Brooks, JSJ, Livolsi, VA, Pietra, GG. Mesothelial cell inclusions in mediastinal lymph nodes mimicking metastatic carcinoma. Am J Clin Pathol 1990–93:741–748.CrossRefGoogle ScholarPubMed
Argani, P, Rosai, J. Hyperplastic mesothelial cells in lymph nodes: Report of six cases of a benign process that can simulate metastatic involvement by mesothelioma or carcinoma. Hum Pathol 1998;29:339–346.CrossRefGoogle ScholarPubMed
Davidson, B, Nielsen, S, Christensen, J, Asschenfeldt, P, Berner, A, Risberg, B. The role of desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells. Am J Surg Pathol 2001;25:1405–1412.CrossRefGoogle ScholarPubMed
Ordonez, NG. Value of immunohistochemistry in distinguishing peritoneal mesothelioma from serous carcinoma of the ovary and peritoneum: a review and update. Adv Anat Pathol 2006;13:16–25.Google ScholarPubMed
Ordonez, NG. The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study. Mod Pathol 2006;19:417–428.CrossRefGoogle ScholarPubMed
Jones, MA, Young, RH, Srigley, JR, Scully, RE. Paratesticular serous papillary carcinoma: A report of six cases. Am J Surg Pathol 1995;19:1359–1365.CrossRefGoogle ScholarPubMed
Lin, BT, Colby, T, Gown, AM, Hammar, SP, Mertens, RB, Churg, A. Malignant vascular tumors of the serous membranes mimicking mesothelioma: A report of 14 cases. Am J Surg Pathol 1996;20:1431–1439.CrossRefGoogle ScholarPubMed
Zhang, PJ, Livolsi, VA, Brooks, JJ. Malignant epithelioid vascular tumors of the pleura: report of a series and literature review. Hum Pathol 2000;31:29–34.CrossRefGoogle ScholarPubMed
Huang, CC, Chang, DY, Chen, CK, Chou, YY, Huang, SC. Adenomatoid tumor of the female genital tract. Int J Gynecol Pathol 1995;50:275–280.CrossRefGoogle ScholarPubMed
Nogales, FF, Isaac, MA, Hardisson, D, Bosincu, L, Palacios, J, Ordi, J. Adenomatoid tumor of the uterus: An analysis of 60 cases. Int J Gynecol Pathol 2001;21:31–40.Google Scholar
Cheng, CL, Wee, A. Diffuse uterine adenomatoid tumor in an immunosuppressed renal transplant recipient. Int J Gynecol Pathol 2003;22:198–201.CrossRefGoogle Scholar
Zamecnik, M, Gomolcak, P. Composite multicystic mesothelioma and adenomatoid tumor of the ovary: additional observation suggesting common histogenesis of both lesions. Cesk Patol 2000;38:160–162.Google Scholar
Broth, G, Bullock, WK, Morrow, J. Epididymal tumors: 1. Report of 15 new cases including review of literature. 2: Histochemical study of the so-called adenomatoid tumor. J Urol 1968;100:530–536.CrossRefGoogle ScholarPubMed
Yasuma, T, Saito, S. Adenomatoid tumor of the male genital tract and a pathological study of eight cases and review of the literature. Acta Pathol Jpn 1980;30:883–906.Google Scholar
Barry, P, Chan, KG, Hsu, J, Quek, ML. Adenomatoid tumor of the tunica albuginea. Int J Urol 2005;12:516–518.CrossRefGoogle ScholarPubMed
Raaf, HN, Grant, LD, Santoscoy, C, Levin, HS, Abdul-Karin, FW. Adenomatoid tumor of the adrenal gland: a report of four new cases and a review of the literature. Mod Pathol 1996;9:1046–1051.Google Scholar
Isotalo, PA, Keeney, GL, Sebo, TJ, Riehle, DL, Cheville, JC. Adenomatoid tumor of the adrenal gland: a clinicopathologic study of five cases and review of the literature. Am J Surg Pathol 2003;27:969–977.CrossRefGoogle ScholarPubMed
Craig, JR, Hart, WR. Extragenital adenomatoid tumor: Evidence for the mesothelial theory of origin. Cancer 1979;43:1678–1681.3.0.CO;2-N>CrossRefGoogle Scholar
Overstreet, K, Wixom, C, Shabaik, A, Bouvet, M, Herndier, B. Adenomatoid tumor of the pancreas: a case report with comparison of histology and aspiration cytology. Mod Pathol 2003;16:613–617.CrossRefGoogle ScholarPubMed
Plaza, J, Dominguez, F, Suster, S. Cystic adenomatoid tumor of the mediastinum. Am J Surg Pathol 2004;28:132–138.CrossRefGoogle ScholarPubMed
Natarajan, S, Luhtringer, DJ, Fishbein, MC. Adenomatoid tumor of the heart: report of a case. Am J Surg Pathol 1997;21:1378–1380.CrossRefGoogle ScholarPubMed
Isotalo, PA, Nascimento, AG, Trastek, VF, Wold, , Cheville, JC. Extragenital adenomatoid tumor of a mediastinal lymph node. Mayo Clin Proc 2003;78:350–354.CrossRefGoogle ScholarPubMed
Skinnider, BF, Young, RH. Infarcted adenomatoid tumor: a report of five cases of a facet of a benign neoplasm that may cause diagnostic difficulty. Am J Surg Pathol 2004;28:77–83.CrossRefGoogle ScholarPubMed
Lehto, VP, Miettinen, M, Virtanen, I. Adenomatoid tumor: Immunohistochemical features suggesting a mesothelial origin. Virchows Arch B Cell Pathol 1983;42:153–159.CrossRefGoogle Scholar
Katsube, Y, Mukai, K, Silverberg, SG. Cystic mesothelioma of the peritoneum: a report of five cases and review of literature. Cancer 1982;50:1615–1622.3.0.CO;2-K>CrossRefGoogle Scholar
Carpenter, HA, Laskaster, JR, Lee, RA. Multilocular cysts of the peritoneum. Mayo Clin Proc 1982;57:634–638.Google ScholarPubMed
Schneider, V, Partridge, JR, Gutierrez, F, Hurt, WG, Maizels, MS, Demay, RM. Benign cystic mesothelioma involving the female genital tract: report of four cases. Am J Obstet Gynecol 1983;145:355–359.CrossRefGoogle ScholarPubMed
Weiss, SW, Tavassoli, FA: Multicystic mesothelioma: An analysis of pathological findings and biologic behavior in 37 cases. Am J Surg Pathol 1988;12:737–746.CrossRefGoogle ScholarPubMed
Villaschi, S, Autelitano, F, Santeusanio, G, Balistreri, P. Cystic mesothelioma of the peritoneum: A report of three cases. Am J Clin Pathol 1990;94:758–761.CrossRefGoogle ScholarPubMed
Cuartas, JE, Maheshwari, AV, Qadir, R, Cooper, AJ, Robinson, PG, Pitcher, JD. Benign multicystic peritoneal mesothelioma in a cesarean-section scar presenting as a fungating mass. Int J Clin Oncol 2008;13:275–278.CrossRefGoogle Scholar
Groisman, GM, Kerner, H. Multicystic mesothelioma with endometriosis. Acta Obstet Gynecol Scand 1992;71:642–644.CrossRefGoogle ScholarPubMed
Zotalis, G, Nayar, R, Hicks, DG. Leiomyomatosis peritonealis disseminata, endometriosis, and multicystic peritoneal mesothelioma: an unusual association. Int J Gynecol Pathol 1998;17:178–182.CrossRefGoogle Scholar
Kusuyama, T, Fujita, M. Appendiceal mucinous cystadenoma associated with pseudomyxoma peritonei and multicystic peritoneal mesothelioma: report of a case. Surg Today 1995;25:745–749.CrossRefGoogle ScholarPubMed
Klooster, JM, Lambers, MD, Bommel, EF, Scholten, PC. Successful catheter drainage of recurrent benign multicystic mesothelioma of the peritoneum. Neth J Med 1997;50:246–249.Google ScholarPubMed
Inman, DS, Lambert, AW, Wilkins, DC. Multicystic peritoneal inclusion cysts: the use of CT-guided drainage for symptom control. Ann R Coll Surg Engl 2000;82:196–197.Google ScholarPubMed
Ball, NJ, Urbanski, SJ, Green, FH, Kieser, T. Pleural multicystic mesothelial proliferation: The so-called multicystic mesothelioma. Am J Surg Pathol 1990;14:375–378.CrossRefGoogle ScholarPubMed
Daya, D, McCaughey, WTE. Well-differentiated papillary mesothelioma of the peritoneum: A clinicopathologic study of 22 cases. Cancer 1990;65:292–296.3.0.CO;2-W>CrossRefGoogle ScholarPubMed
Goepel, JR. Benign papillary mesothelioma of the peritoneum: a histological, histochemical and ultrastructural study of six cases. Histopathology 1981;5:21–30.CrossRefGoogle ScholarPubMed
Goldblum, J, Hart, WR. Localized and diffuse mesotheliomas of the genital tract and peritoneum in women: A clinicopathologic study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multicystic mesotheliomas, and localized fibrous tumors. Am J Surg Pathol 1995;19:1124–1137.CrossRefGoogle ScholarPubMed
Hoekstra, AV, Riben, MW, Frumovitz, M, Liu, J, Ramirez, PT. Well-differentiated papillary mesothelioma of the peritoneum: A pathological analysis and review of the literature. Gynecol Oncol 2005;98:161–167.CrossRefGoogle ScholarPubMed
Butnor, KJ, Sporn, TA, Hammar, SP, Roggli, VL. Well-differentiated papillary mesothelioma. Am J Surg Pathol 2001;25:1304–1309.CrossRefGoogle ScholarPubMed
Galateau-Salle, F, Vignaud, JM, Burke, L, Gibbs, A, Brambilla, E, Attanoos, R. Well-differentiated papillary mesothelioma of the pleura: A series of 24 cases. Am J Surg Pathol 2004;28:534–540.CrossRefGoogle ScholarPubMed
Bianchi, C, Bianchi, T. Malignant mesothelioma: Global incidence and relationship with asbestos. Industrial Health 2007;45:379–387.CrossRefGoogle ScholarPubMed
Weill, H, Hughes, JM, Churg, AM. Changing trends in US mesothelioma incidence. Occup Environ Med 2004;61:438–441.CrossRefGoogle ScholarPubMed
Becklake, MR, Bagatin, E, Neder, JA. Asbestos-related diseases of the lungs and pleura: uses, trends and management over the last century. Int J Tuberc Lung Dis 2007;11:356–369.Google ScholarPubMed
Roggli, VA, Sharma, A, Butnor, KJ, Sporn, T, Vollmer, RT. Malignant mesothelioma and occupational exposure to asbestos: a clinicopathologic correlation of 1445 cases. Ultrastruct Pathol 2002;26:55–65.CrossRefGoogle Scholar
McDonald, JC, McDonald, A. Mesothelioma and asbestos exposure. In: Pass, HI, Vogelzang, NJ, Carbone, M (eds). Malignant Mesothelioma. Berlin-Heidelberg-New York, Springer, 2005.Google Scholar
Wagner, JC, Sleggs, CA, Marchand, P. Diffuse pleural mesothelioma and asbestos exposure in the northwestern Cape province. Br J Industr Med 1980;17:260–271.Google Scholar
Carbone, M, Pass, HI, Rizzo, P, Marinetti, M, DiMuzio, M, Mew, DJ. Simian virus 40-like DNA sequences human pleural mesothelioma. Oncogene 1994;9:1781–1790.Google ScholarPubMed
Strickler, HD, Goedert, JJ, Fleming, M, Travis, WD, Williams, AE, Rabkin, CS. Simian virus 40 and pleural mesothelioma in humans. Cancer Epidemiol Biomarkers Prev 1996:5:473–475.Google ScholarPubMed
Cavazza, A, Travis, LB, Travis, WD, Wolfe, JT, Foo, ML, Gillespie, DJ. Post-irradiation malignant mesothelioma. Cancer 1996;77:1379–1385.3.0.CO;2-Y>CrossRefGoogle ScholarPubMed
Brenner, J, Sordillo, PP, Magill, GB, Golbey, RB. Malignant mesothelioma of the pleura: Review of 123 patients. Cancer 1982;49:2431–2435.3.0.CO;2-W>CrossRefGoogle ScholarPubMed
Adams, VI, Unni, KK, Muhn, JR, Jett, JR, Isltrup, DM, Bernatz, PE. Diffuse malignant mesothelioma of pleura: Diagnosis and survival in 92 cases. Cancer 1986;58:1540–1551.3.0.CO;2-5>CrossRefGoogle ScholarPubMed
Antman, K, Shemin, R, Ryan, L, Klegar, K, Osteen, R, Herman, T. Malignant mesothelioma: Prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965–1985. J Clin Oncol 1988;6:147–153.CrossRefGoogle Scholar
Ruffie, P, Feld, R, Minkin, S, Cormier, Y, Boutan-Laroze, A, Ginsberg, R. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: A retrospective study of 332 patients. J Clin Oncol 1989;7:1157–1168.CrossRefGoogle ScholarPubMed
Antman, KH. Natural history and epidemiology of malignant mesothelioma. Chest 1993;103:373S–376S.CrossRefGoogle ScholarPubMed
Chahinian, AP. Clinical presentation and natural history of mesothelioma: pleural and pericardial. In: Pass, In: HI, Vogelzang, NJ, Carbone, M (eds). Malignant Mesothelioma. Berlin-Heidelberg-New York, Springer, 2005.Google Scholar
Kannerstein, M, Churg, A. Peritoneal mesothelioma. Hum Pathol 1977;8:83–94.CrossRefGoogle ScholarPubMed
Kerrigan, SAJ, Turnnir, RT, Clement, PB, Young, RH, Churg, A. Diffuse malignant epithelial mesotheliomas of the peritoneum in women: A clinicopathologic study of 25 cases. Cancer 2002;94:378–385.CrossRefGoogle Scholar
Baker, PM, Clement, PB, Young, RH. Malignant peritoneal mesothelioma in women: A study of 75 cases with emphasis on their morphologic spectrum and differential diagnosis. Am J Clin Pathol 2005;123:724–737.CrossRefGoogle ScholarPubMed
Hassan, R, Alexander, R, Antman, K, Boffetta, P, Churg, A, Coit, D. Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference. Ann Oncol 2006;17:1615–1619.CrossRefGoogle ScholarPubMed
Jones, MA, Young, RH, Scully, RA. Malignant mesothelioma of the tunica vaginalis: A clinicopathologic analysis of 11 cases with review of the literature. Am J Surg Pathol 1995;19:815–825.CrossRefGoogle ScholarPubMed
Churg, A. Paratesticular mesothelial proliferations. Semin Diagn Pathol 2003;20:272–278.CrossRefGoogle ScholarPubMed
Crotty, TB, Myers, JL, Katzenstein, AL, Tazelaar, HD, Swensen, SJ, Churg, A. Localized malignant mesothelioma: A clinicopathologic and flow cytometric study. Am J Surg Pathol 1994;18:357–363.CrossRefGoogle ScholarPubMed
Allen, TG, Cagle, PT, Churg, AM, Colby, TV, Gibbs, AR, Hammar, SP. Localized malignant mesothelioma. Am J Surg Pathol 2005;29:866–873.CrossRefGoogle ScholarPubMed
Battifora, H, McCaughey, WTE. Tumors of the Serous Membranes. Washington, DC, Armed Forces Institute of Pathology, 1995.
Talerman, A, Chilcote, RR, Montero, JR, Okagaki, T. Diffuse malignant peritoneal mesothelioma in a 13-year-old girl. Am J Surg Pathol 1985;9:73–80.CrossRefGoogle Scholar
Nascimento, AG, Keeney, GL, Fletcher, CDM. Deciduoid peritoneal mesothelioma: an unusual phenotype affecting young females. Am J Surg Pathol 1994;18:439–445.CrossRefGoogle ScholarPubMed
Shanks, JH, Harris, M, Banerjee, SS, Eyden, BP, Joglekar, VM, Nicol, A. Mesotheliomas with deciduoid morphology: A morphologic spectrum and a variant not confined to young females. Am J Surg Pathol 2000;24:285–294.CrossRefGoogle Scholar
Ordonez, NG. Epithelial mesothelioma with deciduoid features: A report of four cases. Am J Surg Pathol 2000;24:816–823.CrossRefGoogle ScholarPubMed
Klebe, S, Mahar, A, Henderson, DW, Roggli, VL. Malignant mesothelioma with heterologous elements: clinicopathologic correlation of 27 cases and literature review. Mod Pathol 2008;21:1084–1094.CrossRefGoogle Scholar
Cantin, R, Al-Jabi, M, McCaughey, WTE. Desmoplastic diffuse mesothelioma. Am J Surg Pathol 1982;6:215–222.CrossRefGoogle ScholarPubMed
Mangano, WE, Cagle, PT, Churg, A, Vollmer, RT, Roggli, VL. The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining. Am J Clin Pathol 1998;110:191–199.CrossRefGoogle Scholar
Carella, R, Deleonardi, G, DíErrico, A, Salerno, A, Egarter-Vigl, A, Seebacher, C. Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: A study with logistic regression analysis. Am J Surg Pathol 2001;25:43–50.CrossRefGoogle ScholarPubMed
Wick, MR, Loy, T, Mills, SE, Legier, JF, Manivel, JC. Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: A histochemical, ultrastructural, and immunohistologic study of 103 cases. Hum Pathol 1990;21:759–766.CrossRefGoogle ScholarPubMed
Sheibani, K, Shin, SS, Kezirian, J, Weiss, LM. Ber-Ep4 antibody as a discriminant in the differential diagnosis of malignant mesothelioma versus adenocarcinoma. Am J Surg Pathol 1991;15:779–784.CrossRefGoogle ScholarPubMed
Amin, KM, Litzky, , Smythe, WR. Wilms tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma. Am J Pathol 1995;146:344–356.Google ScholarPubMed
Attanoos, RL, Goddard, H, Gibbs, AR. Mesothelioma-binding antibodies: thrombomodulin, OV 632 and HBME-1 and their use in the diagnosis of malignant mesothelioma. Histopathology 1996;29:209–215.CrossRefGoogle Scholar
Gotzos, V, Vogt, P, Celio, MR. The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type. Pathol Res Pract 1996;192:137–147.CrossRefGoogle ScholarPubMed
Dei Tos, AP, Doglioni, C. Calretinin: a novel tool for diagnostic immunohistochemistry. Adv Anat Pathol 1998;5:61–66.CrossRefGoogle ScholarPubMed
Riera, JR, Astengo-Osuna, C, Longmate, JA, Battifora, H. The immunohistochemical diagnostic panel for epithelial mesothelioma: A reevaluation after heat-induced epitope retrieval. Am J Surg Pathol 1997;21:1409–1417.CrossRefGoogle ScholarPubMed
Cury, PM, Butcher, DN, Fisher, C, Corrin, B, Nicholson, AG. Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to pleura. Mod Pathol 2000;13:107–112.CrossRefGoogle ScholarPubMed
Blobel, GA, Moll, R, Franke, WW, Kayser, KW, Gould, VE. The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance. Am J Pathol 1985;121:235–247.Google ScholarPubMed
Moll, R, Dhouailly, D, Sun, TT. Expression of keratin 5 as a distinctive feature of epithelial and biphasic mesotheliomas: An immunohistochemical study using monoclonal antibody AE14. Virchows Arch B Cell Pathol 1989;58:129–145.CrossRefGoogle ScholarPubMed
Miettinen, M, Sarlomo-Rikala, M. Expression of calretinin, thrombomodulin, keratin 5, and mesothelin in lung carcinomas of different types: an immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleura. Am J Surg Pathol 2003;27:150–158.CrossRefGoogle ScholarPubMed
Ordonez, NG. What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma. Hum Pathol 2007;38:1–16.CrossRefGoogle Scholar
Suster, S, Moran, CA. Applications and limitations of immunohistochemistry in the diagnosis of malignant mesothelioma. Adv Anat Pathol 2006;13:316–329.CrossRefGoogle Scholar
Lucas, DR, Pass, HI, Madan, SK, Adsay, NV, Wali, A, Tabaczka, P. Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study. Histopathology 2003;42:270–279.CrossRefGoogle ScholarPubMed
Hinterberger, M, Reineke, T, Storz, M, Weder, W, Vogt, P, Moch, H. D2–40 and calretinin – a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation. Mod Pathol 2007;20:248–255.CrossRefGoogle ScholarPubMed
Padgett, DM, Cathro, HP, Wick, MR, Mills, SE. Podoplanin is a better immunohistochemical marker for sarcomatoid mesothelioma than calretinin. Am J Surg Pathol 2008;32:123–127.CrossRefGoogle ScholarPubMed
Bolen, JW, Hammar, SP, McNutt, MA. Reactive and neoplastic serosal tissue: A light-microscopic, ultrastructural, and immunocytochemical study. Am J Surg Pathol 1986;10:34–47.CrossRefGoogle ScholarPubMed
Epstein, JI, Budin, RE. Keratin and epithelial membrane antigen immunoreactivity in nonneoplastic fibrous pleural lesions: implications for the diagnosis of desmoplastic mesothelioma. Hum Pathol 1986;17:514–519.CrossRefGoogle Scholar
Oury, TD, Hammar, SP, Roggli, VL. Ultrastructural features of diffuse malignant mesotheliomas. Hum Pathol 1998;29:1382–1392.CrossRefGoogle ScholarPubMed
Rosai, J, Dehner, LP. Nodular mesothelial hyperplasia in hernia sacs: A benign reactive condition simulating a neoplastic process. Cancer 1975;35:165–175.3.0.CO;2-U>CrossRefGoogle ScholarPubMed
Ordonez, NG, Ro, JY, Ayasla, AG. Lesions described as nodular mesothelial hyperplasia are primarily composed of histiocytes. Am J Surg Pathol 1998;22:285–292.CrossRefGoogle ScholarPubMed
Clement, PB, Young, RH. Florid mesothelial hyperplasia associated with ovarian tumors: A potential source of error in tumor diagnosis and staging. Int J Gynecol Pathol 1993;12:51–58.CrossRefGoogle ScholarPubMed
Churg, A, Colby, TV, Cagle, P, Corson, J, Gibbs, AR, Gilks, B. The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol 2000;24:1183–1200.Google ScholarPubMed
Brooks, JSJ, Livolsi, VA, Pietra, GG. Mesothelial cell inclusions in mediastinal lymph nodes mimicking metastatic carcinoma. Am J Clin Pathol 1990–93:741–748.CrossRefGoogle ScholarPubMed
Argani, P, Rosai, J. Hyperplastic mesothelial cells in lymph nodes: Report of six cases of a benign process that can simulate metastatic involvement by mesothelioma or carcinoma. Hum Pathol 1998;29:339–346.CrossRefGoogle ScholarPubMed
Davidson, B, Nielsen, S, Christensen, J, Asschenfeldt, P, Berner, A, Risberg, B. The role of desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells. Am J Surg Pathol 2001;25:1405–1412.CrossRefGoogle ScholarPubMed
Ordonez, NG. Value of immunohistochemistry in distinguishing peritoneal mesothelioma from serous carcinoma of the ovary and peritoneum: a review and update. Adv Anat Pathol 2006;13:16–25.Google ScholarPubMed
Ordonez, NG. The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study. Mod Pathol 2006;19:417–428.CrossRefGoogle ScholarPubMed
Jones, MA, Young, RH, Srigley, JR, Scully, RE. Paratesticular serous papillary carcinoma: A report of six cases. Am J Surg Pathol 1995;19:1359–1365.CrossRefGoogle ScholarPubMed
Lin, BT, Colby, T, Gown, AM, Hammar, SP, Mertens, RB, Churg, A. Malignant vascular tumors of the serous membranes mimicking mesothelioma: A report of 14 cases. Am J Surg Pathol 1996;20:1431–1439.CrossRefGoogle ScholarPubMed
Zhang, PJ, Livolsi, VA, Brooks, JJ. Malignant epithelioid vascular tumors of the pleura: report of a series and literature review. Hum Pathol 2000;31:29–34.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×